FR2462443B1 - - Google Patents

Info

Publication number
FR2462443B1
FR2462443B1 FR7919296A FR7919296A FR2462443B1 FR 2462443 B1 FR2462443 B1 FR 2462443B1 FR 7919296 A FR7919296 A FR 7919296A FR 7919296 A FR7919296 A FR 7919296A FR 2462443 B1 FR2462443 B1 FR 2462443B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7919296A
Other versions
FR2462443A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7919296A priority Critical patent/FR2462443A1/fr
Priority to SE8004428A priority patent/SE447387B/sv
Priority to HU80801526A priority patent/HU180364B/hu
Priority to ZA00803867A priority patent/ZA803867B/xx
Priority to FI802092A priority patent/FI66880C/fi
Priority to IT49248/80A priority patent/IT1145302B/it
Priority to MX808920U priority patent/MX6649E/es
Priority to CA000356705A priority patent/CA1141751A/fr
Priority to BE0/201544A priority patent/BE884494A/fr
Priority to JP10142880A priority patent/JPS5622798A/ja
Priority to NL8004282A priority patent/NL8004282A/nl
Priority to DE3028255A priority patent/DE3028255C2/de
Priority to DK321180A priority patent/DK146690C/da
Priority to IE1561/80A priority patent/IE50031B1/en
Priority to NO802256A priority patent/NO153102C/no
Priority to CH573280A priority patent/CH645389A5/fr
Priority to AU60811/80A priority patent/AU528292B2/en
Priority to GB8024660A priority patent/GB2054600B/en
Priority to AT0391380A priority patent/AT371483B/de
Publication of FR2462443A1 publication Critical patent/FR2462443A1/fr
Priority to US06/300,252 priority patent/US4353899A/en
Application granted granted Critical
Publication of FR2462443B1 publication Critical patent/FR2462443B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7919296A 1979-07-26 1979-07-26 Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament Granted FR2462443A1 (fr)

Priority Applications (20)

Application Number Priority Date Filing Date Title
FR7919296A FR2462443A1 (fr) 1979-07-26 1979-07-26 Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
SE8004428A SE447387B (sv) 1979-07-26 1980-06-13 Nytt halogenerat derivat i 16alfa-metyl pregnanserien, dess anvendning for framstellning av ett lekemedel med antiinflammatorisk aktivitet samt farmaceutiska kompositioner innehallande denna
HU80801526A HU180364B (en) 1979-07-26 1980-06-19 Process for preparing 9alpha,11beta-dichloro-16alpha-methyl-21-/dicyclohexyl-methoxy-carbonyl-oxy/-pregna-1,4-diene-3,20-dione
ZA00803867A ZA803867B (en) 1979-07-26 1980-06-26 Halogenated derivative of the 16a-methyl pregnane series, its preparation, its application as a medicament and the compositions containing it
FI802092A FI66880C (fi) 1979-07-26 1980-07-01 Foerfarande foer framstaellning av ett terapeutiskt anvaendbart till 16alfa-metylpregnan-serien hoerande nytt halogenderivat
IT49248/80A IT1145302B (it) 1979-07-26 1980-07-15 Derivati alogenati della serie del 16alfa-metil-fregnano composizioni che lo contengono e procedimento per la loro preparazione
MX808920U MX6649E (es) 1979-07-26 1980-07-15 Procedimiento para preparar 9alpha,11b-dicloro-16alpha metil-21-oxicarbonildiciclohexilmetil-oxi-pregna-1,4-dieno-3,20-diona
CA000356705A CA1141751A (fr) 1979-07-26 1980-07-22 PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE HALOGENE DE LA SERIE DU 16.alpha.-METHYL PREGNANE
CH573280A CH645389A5 (fr) 1979-07-26 1980-07-25 Derive halogene de la serie du 16alpha-methyl pregnane, sa preparation et composition le renfermant.
NL8004282A NL8004282A (nl) 1979-07-26 1980-07-25 Halogeenderivaat uit de 16alfa-methylpregnaanreeks, werkwijze voor het bereiden daarvan alsmede farmaceu- tische preparaten op basis daarvan.
BE0/201544A BE884494A (fr) 1979-07-26 1980-07-25 Nouveau derive halogene de la serie du 16alpha-methyl pregnane, sa preparation, son application comme medicament et les compositions le renfermant
DK321180A DK146690C (da) 1979-07-26 1980-07-25 Analogifremgangsmaade til fremstilling af 9alfa,11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion
IE1561/80A IE50031B1 (en) 1979-07-26 1980-07-25 A new halogenated 16alpha-methyl-pregnane derivative
NO802256A NO153102C (no) 1979-07-26 1980-07-25 Analogifremgangsmaate for fremstilling av terapeutisk aktiv 9 alfa, 11 beta-diklor-16 alfa-methyl-21-oxycarbonyldicyclohexyl-methyloxypregna-1,4-dien-3,20-dion.
JP10142880A JPS5622798A (en) 1979-07-26 1980-07-25 Novel halogenated derivative of 16 alphaamethylpregnane* its manufacture* use as drug and composition containing it
AU60811/80A AU528292B2 (en) 1979-07-26 1980-07-25 Halogenated 16alpha-methyl pregnane
DE3028255A DE3028255C2 (de) 1979-07-26 1980-07-25 9α,11β-Dichlor-16α-methyl-21-oxycarbonyldicyclohexyl-methyloxypregan-1,4-dien-3,20-dion, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen
GB8024660A GB2054600B (en) 1979-07-26 1980-07-28 Halogenated 16-methyl-pregnane derivative
AT0391380A AT371483B (de) 1979-07-26 1980-07-28 Verfahren zur herstellung eines neuen halogenderivates der 16 alpha-methylpregnanreihe
US06/300,252 US4353899A (en) 1979-07-26 1981-09-08 Novel 16α-methyl-pregnane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7919296A FR2462443A1 (fr) 1979-07-26 1979-07-26 Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament

Publications (2)

Publication Number Publication Date
FR2462443A1 FR2462443A1 (fr) 1981-02-13
FR2462443B1 true FR2462443B1 (fr) 1982-12-31

Family

ID=9228325

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7919296A Granted FR2462443A1 (fr) 1979-07-26 1979-07-26 Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament

Country Status (20)

Country Link
US (1) US4353899A (fr)
JP (1) JPS5622798A (fr)
AT (1) AT371483B (fr)
AU (1) AU528292B2 (fr)
BE (1) BE884494A (fr)
CA (1) CA1141751A (fr)
CH (1) CH645389A5 (fr)
DE (1) DE3028255C2 (fr)
DK (1) DK146690C (fr)
FI (1) FI66880C (fr)
FR (1) FR2462443A1 (fr)
GB (1) GB2054600B (fr)
HU (1) HU180364B (fr)
IE (1) IE50031B1 (fr)
IT (1) IT1145302B (fr)
MX (1) MX6649E (fr)
NL (1) NL8004282A (fr)
NO (1) NO153102C (fr)
SE (1) SE447387B (fr)
ZA (1) ZA803867B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT385996B (de) * 1982-10-05 1988-06-10 Roussel Uclaf Verfahren zur herstellung neuer dichlorierter derivate aus der reihe der 16alpha -methylpregnane

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2561919B1 (fr) * 1984-04-03 1986-12-19 Roussel Uclaf Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon
DE19932511A1 (de) * 1999-07-12 2001-01-18 Helmig Hans Gmbh Schaltvorrichtung für eine Kettengangschaltung zur Betätigung der Kettenradgruppe an der Tretkurbel eines Fahrrades

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL122815C (fr) * 1963-12-19
FR2342738A1 (fr) * 1976-03-02 1977-09-30 Roussel Uclaf Nouveaux derives halogenes de la serie du 16a-methyl pregnane
FR2381065A2 (fr) * 1977-02-22 1978-09-15 Roussel Uclaf Nouveaux derives halogenes de la serie du 16 a-methyl pregnane

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT385996B (de) * 1982-10-05 1988-06-10 Roussel Uclaf Verfahren zur herstellung neuer dichlorierter derivate aus der reihe der 16alpha -methylpregnane

Also Published As

Publication number Publication date
NO153102B (no) 1985-10-07
HU180364B (en) 1983-02-28
JPS5622798A (en) 1981-03-03
IT8049248A0 (it) 1980-07-15
FI802092A (fi) 1981-01-27
DK146690C (da) 1984-05-21
IT1145302B (it) 1986-11-05
SE8004428L (sv) 1981-01-27
IE801561L (en) 1981-01-26
SE447387B (sv) 1986-11-10
IE50031B1 (en) 1986-02-05
GB2054600B (en) 1983-02-02
NL8004282A (nl) 1981-01-28
CH645389A5 (fr) 1984-09-28
NO153102C (no) 1986-01-15
US4353899A (en) 1982-10-12
GB2054600A (en) 1981-02-18
CA1141751A (fr) 1983-02-22
BE884494A (fr) 1981-01-26
AU6081180A (en) 1981-01-29
ATA391380A (de) 1982-11-15
DK321180A (da) 1981-01-27
FR2462443A1 (fr) 1981-02-13
FI66880B (fi) 1984-08-31
DE3028255A1 (de) 1981-02-19
NO802256L (no) 1981-01-27
ZA803867B (en) 1981-06-24
DK146690B (da) 1983-12-05
DE3028255C2 (de) 1985-12-19
JPS6254438B2 (fr) 1987-11-14
MX6649E (es) 1985-10-01
AU528292B2 (en) 1983-04-21
AT371483B (de) 1983-06-27
FI66880C (fi) 1984-12-10

Similar Documents

Publication Publication Date Title
BR8002583A (fr)
BR8006808A (fr)
FR2446094B3 (fr)
FR2462443B1 (fr)
AU78390S (fr)
AU79200S (fr)
AU78271S (fr)
AU78385S (fr)
AU78386S (fr)
AU78389S (fr)
AU77763S (fr)
AU77669S (fr)
AU78569S (fr)
AU78270S (fr)
AU79557S (fr)
AU79558S (fr)
AU79559S (fr)
AU79826S (fr)
AU79918S (fr)
AU79950S (fr)
AU80228S (fr)
AU78391S (fr)
BR5901094U (fr)
BG28434A1 (fr)
BG28730A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse
ST Notification of lapse